Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Bracelet

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Jun 21, 2024 11:35am

50 Views

Post# 36100029

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Bracelet

Hey Norm, you took longer than I thought to reply. Welcome back. BTW, I don't lie or post disinformation and if I make a correction it is from either a pr or a sedar doc.
Knowing you my guess is you are one of those people that are ok with managment spending 69k dollars of shareholder money to have someone tell them that they are underpaid and deserve a raise even though they are making millions. That shows a lot of entitlement considering the shareholder value that they have proven to all of us.
Also, I have not bashed the science in any way, only managment for what has or has not happened and for the mistakes and misleading information that they have put out.

<< Previous

Bullboard Posts

Next >>

High Tide adds two stores to undervalued cannabis retail network